GLP-1 weight loss drugs containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with serious heart conditions, according to new research.Read More
Mounjaro, Zepbound Lower Death Risk for People With Serious Heart Conditions
